PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

309 articles indexed across 20 specialties, each reviewed by a licensed pharmacist before publication.

⭐ Featured free samples

Three of our best full deep-analysis reports: hand-picked, free to read in full, no subscription required.

🔓 Free Sample
Nephrology / Renal Pharmacy ConfirmatoryGrade: Moderate

Finerenone Outperforms Spironolactone for Cardiorenal Protection in Moderate CKD

Published in: American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions · Jul 20, 2026

Finerenone emerges as the safer choice for CKD patients.

Read Free →
🔓 Free Sample
Neurology / Neuropharmacology ConfirmatoryGrade: Low

Tenecteplase Shortens Stroke Treatment and Transfer Times

Published in: JAMA Network Open · Jul 13, 2026

Tenecteplase speeds up stroke thrombolysis compared to alteplase.

Read Free →
🔓 Free Sample
Rheumatology / Immunology ConfirmatoryGrade: Moderate

EULAR 2025 Streamlines Rheumatoid Arthritis DMARD Management to Nine Recommendations

Published in: Annals of the Rheumatic Diseases · Jun 13, 2026

New EULAR guidelines redefine RA management with DMARDs.

Read Free →
Showing 3 from 1 topic.Sort: Newest | Oldest
OTC Naloxone Reaches Only 61% of US Pharmacies Same-Day
Analysis Behavioral Health / Addiction Medicine Confirmatory Grade: Moderate
Eldridge LA, Kline D, Fields K, et al.
Jul 17, 2026 · Published in: JAMA Network Open

Over-the-counter naloxone is unevenly available across U.S. pharmacies.

Stepped-Care Smoking Cessation: Meds First, Devices and Harm Reduction Later
Analysis Behavioral Health / Addiction Medicine Confirmatory Grade: Low
Croghan IT, Hurt RT, Elrashidi MY, et al.
Jul 13, 2026 · Published in: Journal of Primary Care & Community Health

Maximize smoking cessation success with new digital and harm-reduction tools.

Semaglutide cuts heavy drinking in alcohol use disorder with obesity
Analysis Behavioral Health / Addiction Medicine Hypothesis-generating Grade: Moderate
Klausen MK, Justesen SK, Pedersen JN, et al.
May 2, 2026 · Published in: Lancet

Semaglutide reduces alcohol intake in comorbid obesity.